GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma

Oral Oncology

Volumn 48, Issue 7, 2012, Pages 608-614

  Schiegnitz, E ^a   Kammerer P W ^a   Koch, F P ^a   Kruger M ^a   Berres, M ^b,c   Al Nawas, B ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES KOBLENZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Apoptosis; Growth differentiation factor 15 (GDF 15); Oral squamous cell carcinoma (OSCC); Prognosis; Serum marker

Indexed keywords

CASPASE 3; CASPASE 7; GROWTH DIFFERENTIATION FACTOR 15;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CASPASES; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862301596     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.01.020     Document Type: Article

References (31)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2 2005 74 108 (Pubitemid 40372904)
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49(1):8-31, 1.
3. S. Silverman Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge J Am Dent Assoc 132 Suppl. 2001 7S 11S
4. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, and X.Y. He MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci USA 94 21 1997 11514 11519 (Pubitemid 27451030)
5. M. Bottner, C. Suter-Crazzolara, A. Schober, and K. Unsicker Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues Cell Tissue Res 297 1 1999 103 110 (Pubitemid 29313281)
6. E.C. Hsiao, L.G. Koniaris, T. Zimmers-Koniaris, S.M. Sebald, T.V. Huynh, and S.J. Lee Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 10 2000 3742 3751 (Pubitemid 30243919)
7. A. Schober, M. Bottner, J. Strelau, R. Kinscherf, G.A. Bonaterra, and M. Barth Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain J Comp Neurol 439 1 2001 32 45
8. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc Natl Acad Sci USA 97 1 2000 109 114 (Pubitemid 30055792)
9. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, and A.R. Bauskin Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci USA 100 6 2003 3410 3415 (Pubitemid 36356597)
10. P.X. Li, J. Wong, A. Ayed, D. Ngo, A.M. Brade, and C. Arrowsmith Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J Biol Chem 275 26 2000 20127 20135 (Pubitemid 30441624)
11. D.A. Brown, R.L. Ward, P. Buckhaults, T. Liu, K.E. Romans, and N.J. Hawkins MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma Clin Cancer Res 9 7 2003 2642 2650 (Pubitemid 36842108)
12. J. Koopmann, P. Buckhaults, D.A. Brown, M.L. Zahurak, N. Sato, and N. Fukushima Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers Clin Cancer Res 10 7 2004 2386 2392 (Pubitemid 38445697)
13. S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities Mol Pharmacol 59 4 2001 901 908 (Pubitemid 32274020)
14. S. Chen, D. Karan, and S. Johansson Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells Prostate 67 2007 557 571 (Pubitemid 46536948)
15. L. Zhang, X. Yang, H.Y. Pan, X.J. Zhou, J. Li, and W.T. Chen Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma Oral Oncol 45 7 2009 627 632
16. C.J. Lin, J.R. Grandis, T.E. Carey, S.M. Gollin, T.L. Whiteside, and W.M. Koch Head and neck squamous cell carcinoma cell lines: established models and rationale for selection Head Neck 29 2 2007 163 188 (Pubitemid 46167784)
17. J.R. Lambert, J.A. Kelly, M. Shim, W.E. Huffer, S.K. Nordeen, and S.J. Baek Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth J Cell Physiol 208 2006 566 574 (Pubitemid 44141881)
18. M. Shim, and T.E. Eling Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells J Biol Chem 280 19 2005 18636 18642 (Pubitemid 41379563)
19. M. Mimeault, and S.K. Batra Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer J Cell Physiol 224 3 2010 626 635
20. T. Liu, A.R. Bauskin, J. Zaunders, D.A. Brown, S. Pankhurst, and P.J. Russell Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells Cancer Res 63 16 2003 5034 5040 (Pubitemid 37022642)
21. S. Subramaniam, J. Strelau, and K. Unsicker Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways J Biol Chem 278 11 2003 8904 8912 (Pubitemid 36800366)
22. R. Graichen, D. Liu, Y. Sun, K.O. Lee, and P.E. Lobie Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells J Biol Chem 277 29 2002 26662 26672 (Pubitemid 34967165)
23. D.A. Brown, T. Liu, R.L. Ward, N.J. Hawkins, W.D. Fairlie, and A.R. Bauskin Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia J Leukoc Biol 69 Suppl. 2001 90
24. T. Kempf, R. Horn-Wichmann, G. Brabant, T. Peter, T. Allhoff, and G. Klein Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay Clin Chem 53 2 2007 284 291 (Pubitemid 46338273)
25. M. Shiraki, T. Odajima, T. Ikeda, A. Sasaki, M. Satoh, and A. Yamaguchi Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer Mod Pathol 18 11 2005 1482 1489 (Pubitemid 41509403)
26. K. Laimer, G. Spizzo, G. Gastl, P. Obrist, T. Brunhuber, and D. Fong High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis Oral Oncol 43 2 2007 193 198 (Pubitemid 46176708)
27. L.R. de Oliveira, A. Ribeiro-Silva, and S. Zucoloto Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma J Oral Pathol Med 36 4 2007 191 197 (Pubitemid 46495983)
28. L.R. Oliveira, A. Ribeiro-Silva, J.P. Costa, A.L. Simoes, M.A. Matteo, and S. Zucoloto Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 5 2008 685 695
29. M. Luukkaa, P. Vihinen, P. Kronqvist, T. Vahlberg, S. Pyrhonen, and V.M. Kahari Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer Head Neck 28 3 2006 225 234 (Pubitemid 43269889)
30. A. Kosunen, R. Pirinen, K. Ropponen, M. Pukkila, J. Kellokoski, and J. Virtaniemi CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma Oral Oncol 43 1 2007 51 59 (Pubitemid 46162248)
31. J.C. de Vicente, M.F. Fresno, L. Villalain, J.A. Vega, and G. Hernandez Vallejo Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma Oral Oncol 41 3 2005 283 293 (Pubitemid 40311757)